Evidence_NN
that_IN
calcineurin_NN
is_VBZ
rate-limiting_JJ
for_IN
primary_JJ
human_JJ
lymphocyte_NN
activation_NN
._.

Cyclosporine_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
is_VBZ
both_CC
a_DT
clinical_JJ
immunosuppressive_JJ
drug_NN
and_CC
a_DT
probe_NN
to_TO
dissect_VB
intracellular_JJ
signaling_NN
pathways_NNS
._.

In_FW
vitro_FW
,_,
CsA_NN
inhibits_VBZ
lymphocyte_NN
gene_NN
activation_NN
by_IN
inhibiting_VBG
the_DT
phosphatase_NN
activity_NN
of_IN
calcineurin_NN
-LRB-_-LRB-
CN_NN
-RRB-_-RRB-
._.

In_IN
clinical_JJ
use_NN
,_,
CsA_NN
treatment_NN
inhibits_VBZ
50-75_CD
%_NN
of_IN
CN_NN
activity_NN
in_IN
circulating_VBG
leukocytes_NNS
._.

We_PRP
modeled_VBD
this_DT
degree_NN
of_IN
CN_NN
inhibition_NN
in_IN
primary_JJ
human_JJ
leukocytes_NNS
in_IN
vitro_FW
in_FW
order_NN
to_TO
study_VB
the_DT
effect_NN
of_IN
partial_JJ
CN_NN
inhibition_NN
on_IN
the_DT
downstream_JJ
signaling_NN
events_NNS
that_WDT
lead_VBP
to_TO
gene_NN
activation_NN
._.

In_IN
CsA-treated_JJ
leukocytes_NNS
stimulated_VBN
by_IN
calcium_NN
ionophore_NN
,_,
the_DT
degree_NN
of_IN
reduction_NN
in_IN
CN_NN
activity_NN
was_VBD
accompanied_VBN
by_IN
a_DT
similar_JJ
degree_NN
of_IN
inhibition_NN
of_IN
each_DT
event_NN
tested_VBN
:_:
dephosphorylation_NN
of_IN
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cell_NN
proteins_NNS
,_,
nuclear_JJ
DNA_NN
binding_VBG
,_,
activation_NN
of_IN
a_DT
transfected_VBN
reporter_NN
gene_NN
construct_NN
,_,
IFN-gamma_NN
and_CC
IL-2_NN
mRNA_NN
accumulation_NN
,_,
and_CC
IFN-gamma_NN
production_NN
._.

Furthermore_RB
,_,
the_DT
degree_NN
of_IN
CN_NN
inhibition_NN
was_VBD
reflected_VBN
by_IN
a_DT
similar_JJ
degree_NN
of_IN
reduction_NN
in_IN
lymphocyte_NN
proliferation_NN
and_CC
IFN-gamma_NN
production_NN
in_IN
the_DT
allogeneic_JJ
mixed_JJ
lymphocyte_NN
cultures_NNS
._.

These_DT
data_NNS
support_VBP
the_DT
conclusion_NN
that_IN
CN_NN
activity_NN
is_VBZ
rate-limiting_JJ
for_IN
the_DT
activation_NN
of_IN
primary_JJ
human_JJ
T_NN
lymphocytes_NNS
._.

Thus_RB
,_,
the_DT
reduction_NN
of_IN
CN_NN
activity_NN
observed_VBN
in_IN
CsA-treated_JJ
patients_NNS
is_VBZ
accompanied_VBN
by_IN
a_DT
similar_JJ
degree_NN
of_IN
reduction_NN
in_IN
lymphocyte_NN
gene_NN
activation_NN
,_,
and_CC
accounts_VBZ
for_IN
the_DT
immunosuppression_NN
observed_VBN
._.

